Add Yahoo as a preferred source to see more of our stories on Google. Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show ...
Biodesix (NASDAQ:BDSX) outlined its current commercial focus, growth priorities, and financial milestones during a ...
InvestorsHub on MSN
BioAffinity launches large-scale clinical study for lung cancer detection technology
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
Please provide your email address to receive an email when new articles are posted on . Several characteristics known to be related to lung cancer were observed among those with incidentally detected ...
OAK BROOK, Ill. – A new study of more than 10,000 non-smoking adults found that solid lung nodules were present in a considerable portion of study participants. Non-smokers are traditionally thought ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A greater proportion of men vs. women nonsmokers had a ...
SAN ANTONIO, March 10, 2026--bioAffinity Technologies launches 2,000-patient longitudinal study for its CyPath Lung noninvasive diagnostic for lung cancer.
Radiologists using artificial intelligence (AI)-based software in real clinical practice were better able to detect lung nodules on chest radiographs than radiologists using radiographs alone, ...
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced that WPS Government Health Administrators, ...
The study, published in JAMA Network Open, followed more than 19,000 participants undergoing low-dose computed tomography screenings or the lung nodule program. The data, collected between January ...
A U.S.-based diagnostics company is expanding its presence in lung cancer with the acquisition of assets from a firm based in the U.K. Boulder, Colorado-based Biodesix said Friday that it would buy ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results